No Data
Anhui Huangshan Capsule (002817.SZ): No information has been received regarding the controlling Shareholder's plans for restructuring or asset injection.
On March 17, Gelonghui reported that Anhui Huangshan Capsule (002817.SZ) stated on the investor interaction platform that the company's main Business is the research, development, production, and sales of hollow capsules. As of now, the company has not been informed of any plans for restructuring or asset injection by the controlling Shareholder. If there are any related matters, the company will strictly comply with relevant requirements and fulfill information disclosure obligations in a timely manner.
Anhui Huangshan Capsule (002817.SZ) intends to distribute 0.27 yuan for every 10 shares, with the ex-rights and ex-dividend date on January 7.
Anhui Huangshan Capsule (002817.SZ) announced that the proposed equity distribution for the first three quarters of 2024 is: to distribute to all Shareholders according to...
Huangshan Capsule: Report for the third quarter of 2024
Anhui Huangshan Capsule's (SZSE:002817) Sluggish Earnings Might Be Just The Beginning Of Its Problems
Anhui Huangshan Capsule: Summary of Half-Year Report in 2024.
Anhui Huangshan Capsule: Half-year report for the year 2024.
Anhui Huangshan Capsule Co., Ltd.'s (SZSE:002817) Popularity With Investors Under Threat As Stock Sinks 27%
